Suppr超能文献

DiGeorge综合征和腭心面综合征患者的T细胞受体库及功能

T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome.

作者信息

Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, Digilio M C, Giannotti A, Novelli G, Dallapiccola B, Aiuti F, Pandolfi F

机构信息

Chair of Clinical Immunology and Allergy, Department of Clinical Medicine, University of Rome 'La Sapienza', Italy.

出版信息

Clin Exp Immunol. 2000 Jul;121(1):127-32. doi: 10.1046/j.1365-2249.2000.01247.x.

Abstract

DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS) are associated with chromosome 22q11.2 deletion. Limited information is available on the T cell receptor (TCR) Vbeta repertoire. We therefore investigated TCR Vbeta families in lymphocytes isolated from blood and thymic samples of seven patients with DGS and seven patients with VCFS, all with 22q11.2 deletion. We also studied activities related to TCR signalling including in vitro proliferation, anti-CD3-induced protein tyrosine phosphorylation, and susceptibility to apoptosis. Reduced CD3+ T cells were observed in most patients. Spontaneous improvement of T cell numbers was detected in patients, 3 years after the first study. Analysis of CD4+ and CD8+ TCR Vbeta repertoire in peripheral and thymic cells showed a normal distribution of populations even if occasional deletions were observed. Lymphoproliferative responses to mitogens were comparable to controls as well as anti-CD3-induced protein tyrosine phosphorylation. Increased anti-CD3-mediated apoptosis was observed in thymic cells. Our data support the idea that in patients surviving the correction of cardiac anomalies, the immune defect appears milder than originally thought, suggesting development of a normal repertoire of mature T cells.

摘要

迪格奥尔格综合征(DGS)和腭心面综合征(VCFS)与22q11.2染色体缺失有关。关于T细胞受体(TCR)Vβ库的信息有限。因此,我们研究了从7例DGS患者和7例VCFS患者的血液和胸腺样本中分离出的淋巴细胞中的TCR Vβ家族,所有患者均有22q11.2缺失。我们还研究了与TCR信号传导相关的活动,包括体外增殖、抗CD3诱导的蛋白酪氨酸磷酸化以及对凋亡的易感性。在大多数患者中观察到CD3+ T细胞减少。在首次研究3年后,患者的T细胞数量出现自发改善。对外周血和胸腺细胞中CD4+和CD8+ TCR Vβ库的分析显示,即使偶尔观察到缺失,群体分布仍正常。对有丝分裂原的淋巴细胞增殖反应与对照组以及抗CD3诱导的蛋白酪氨酸磷酸化相当。在胸腺细胞中观察到抗CD3介导的凋亡增加。我们的数据支持这样一种观点,即在心脏异常得到纠正后存活的患者中,免疫缺陷似乎比最初认为的要轻,这表明成熟T细胞的正常库正在发育。

相似文献

1
T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome.
Clin Exp Immunol. 2000 Jul;121(1):127-32. doi: 10.1046/j.1365-2249.2000.01247.x.
2
Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
Scand J Immunol. 2011 Jun;73(6):577-85. doi: 10.1111/j.1365-3083.2011.02527.x.
5
Transplantation of thymus tissue in complete DiGeorge syndrome.
N Engl J Med. 1999 Oct 14;341(16):1180-9. doi: 10.1056/NEJM199910143411603.
6
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome.
Blood. 2004 Feb 1;103(3):1020-5. doi: 10.1182/blood-2003-08-2824. Epub 2003 Oct 2.
8
Clinical and immunophenotypic features of atypical complete DiGeorge syndrome.
Pediatr Int. 2013 Feb;55(1):2-6. doi: 10.1111/j.1442-200X.2012.03722.x. Epub 2012 Dec 11.
9
Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
Clin Exp Immunol. 2006 Apr;144(1):85-93. doi: 10.1111/j.1365-2249.2006.03038.x.

引用本文的文献

1
Review of the Pathophysiology and Clinical Manifestations of 22q11.2 Deletion and Duplication Syndromes.
Clin Rev Allergy Immunol. 2025 Mar 4;68(1):23. doi: 10.1007/s12016-025-09035-4.
4
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS.
J Allergy Clin Immunol Pract. 2023 Jan;11(1):292-305.e2. doi: 10.1016/j.jaip.2022.10.010. Epub 2022 Oct 21.
5
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.
J Clin Immunol. 2019 Jan;39(1):65-74. doi: 10.1007/s10875-018-0579-7. Epub 2018 Dec 19.
6
Clinical and molecular cytogenetic studies of an unrecognised 22q11.2 deletion in three families.
Exp Ther Med. 2015 Mar;9(3):823-828. doi: 10.3892/etm.2015.2200. Epub 2015 Jan 21.
8
Primary immunodeficiency diagnosed at autopsy: a case report.
BMC Res Notes. 2014 Jul 4;7:425. doi: 10.1186/1756-0500-7-425.
10
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Clin Immunol. 2010 Sep;136(3):409-18. doi: 10.1016/j.clim.2010.04.011. Epub 2010 May 15.

本文引用的文献

1
Transplantation of thymus tissue in complete DiGeorge syndrome.
N Engl J Med. 1999 Oct 14;341(16):1180-9. doi: 10.1056/NEJM199910143411603.
3
A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.
Science. 1999 Feb 19;283(5405):1158-61. doi: 10.1126/science.283.5405.1158.
4
Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly.
Clin Exp Immunol. 1998 Jul;113(1):65-71. doi: 10.1046/j.1365-2249.1998.00629.x.
5
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L).
Biochim Biophys Acta. 1998 Mar 9;1396(2):158-62. doi: 10.1016/s0167-4781(97)00211-x.
8
Complete DiGeorge syndrome: persistence of profound immunodeficiency.
J Pediatr. 1998 Jan;132(1):15-21. doi: 10.1016/s0022-3476(98)70478-0.
9
UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome.
Hum Mol Genet. 1997 Feb;6(2):259-65. doi: 10.1093/hmg/6.2.259.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验